High-Flow Nasal Cannula Failure Odds Is Largely Independent of Duration of Use in COVID-19

Am J Respir Crit Care Med. 2022 May 15;205(10):1240-1243. doi: 10.1164/rccm.202111-2509LE.

Authors

Hayley B Gershengorn^{1

2}, Ivan Pavlov³, Yonatan Perez^{4

5}, Elsa Tavernier^{6

7}, Miguel Ibarra-Estrada⁸, David Vines⁹, Bairbre McNicholas^{10

11

12}, Oriol Roca^{13

14}, Stephan Ehrmann^{4

5}, John G Laffey^{10

11

12}, Jie Li⁹

Affiliations

¹ University of Miami Miller School of Medicine Miami, Florida.
² Albert Einstein College of Medicine Bronx, New York.
³ Hôpital de Verdun Montréal, Québec, Canada.
⁴ FCRIN Research Network Tours, France.
⁵ Université de Tours Tours, France.
⁶ CHRU Tours Tours, France.
⁷ INSERM UMR 1246 Nantes, France.
⁸ Hospital Civil Fray Antonio Alcalde Guadalajara, Jalisco, México.
⁹ Rush University Chicago, Illinois.
¹⁰ Galway University Hospitals Galway, Ireland.
¹¹ HRB Galway Clinical Research Facility Galway, Ireland.
¹² National University of Ireland Galway, Ireland.
¹³ Hospital Universitari Vall d'Hebron Barcelona, Spain.
¹⁴ Instituto de Salud Carlos III Madrid, Spain.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Cannula
Humans
Noninvasive Ventilation*
Oxygen Inhalation Therapy
Respiratory Insufficiency* / therapy
SARS-CoV-2